The impact of exacerbation frequency on clinical and economic outcomes in Swedish copd patients: The arctic study

13Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Purpose: The aim of this study was to assess the association between exacerbation frequency and clinical and economic outcomes in patients with COPD. Patients and Methods: Electronic medical record data linked to National Health Registries were collected from COPD patients at 52 Swedish primary care centers (2000–2014). The outcomes analyzed were exacerbation rate, mortality, COPD treatments, lung function and healthcare costs during the follow-up period. Based on the exacerbation rate two years before index date, the patients were initially classified into three groups, either 0, 1 or ≥2 exacer-bations per year. After the index date, the classification into exacerbation groups was updated each year based on the exacerbation rate during the last year of follow-up. A sensitivity analysis was conducted excluding patients with asthma diagnosis from the analysis. Results: In total 18,586 COPD patients were analyzed. A majority of the patients (60–70%) who either have had no exacerbation or frequent exacerbations (≥2/year) during the pre-index period remained in their group (ie, with 0 or ≥2 annual exacerbations) during up to 11 years of follow-up. Compared with having no exacerbation, mortality was higher in patients having 1 (HR; 2.06 [1.93–2.20]) and ≥2 (4.58 [4.33–4.84]) exacerbations at any time during the follow-up. Lung function decline was more rapid in patients with frequent exacerbations and there was an almost linear relationship between exacerbations frequency and mortality. Total healthcare costs were higher in the frequent exacerbation group (≥2/year) than in patients with no or one exacerbation annually (p<0.0001 for both). The results did not differ from the main analysis after exclusion of patients with a concurrent asthma diagnosis. Conclusion: In addition to faster lung function decline and increased mortality, frequent exacerbations in COPD patients imply a significant economic burden.

References Powered by Scopus

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010

11175Citations
N/AReaders
Get full text

Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper

3671Citations
N/AReaders
Get full text

Susceptibility to exacerbation in chronic obstructive pulmonary disease

2371Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients

15Citations
N/AReaders
Get full text

Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study

8Citations
N/AReaders
Get full text

DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach

8Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Larsson, K., Janson, C., Lisspers, K., Ställberg, B., Johansson, G., Gutzwiller, F. S., … Jorgensen, L. (2021). The impact of exacerbation frequency on clinical and economic outcomes in Swedish copd patients: The arctic study. International Journal of COPD, 16, 701–713. https://doi.org/10.2147/COPD.S297943

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

78%

Researcher 2

22%

Readers' Discipline

Tooltip

Nursing and Health Professions 3

38%

Medicine and Dentistry 2

25%

Social Sciences 2

25%

Environmental Science 1

13%

Save time finding and organizing research with Mendeley

Sign up for free